Evaluation of aminohydantoins as a novel class of antimalarial agents

ACS Medicinal Chemistry Letters

Volumn 5, Issue 1, 2014, Pages 89-93

  Meyers, Marvin J ^a   Tortorella, Micky D ^b   Xu, Jing ^b   Qin, Limei ^b   He, Zhengxiang ^b   Lang, Xingfen ^b   Zeng, Wentian ^b   Xu, Wanwan ^b   Qin, Li ^b   Prinsen, Michael J ^a   Sverdrup, Francis M ^a   Eickhoff, Christopher S ^a   Griggs, David W ^a   Oliva, Jonathan ^a   Ruminski, Peter G ^a   Jacobsen, E Jon ^a   Campbell, Mary A ^a   Wood, David C ^a   Goldberg, Daniel E ^c   Liu, Xiaorong ^b   Lu, Yongzhi ^b   Lu, Xin ^b   Tu, Zhengchao ^b   Lu, Xiaoyun ^b   Ding, Ke ^b   Chen, Xiaoping ^b   more..

^a SAINT LOUIS UNIVERSITY   (United States)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aminohydantoin; antimalarial; aspartic protease inhibitors; Malaria; medicinal chemistry

Indexed keywords

ANTIMALARIAL AGENT; ASPARTIC PROTEINASE; CWHM 117; NITROFURANTOIN; TCMDC 136879; UNCLASSIFIED DRUG;

ARTICLE; DRUG SCREENING; ENZYME INHIBITION; IC 50; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84892611318     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400412x     Document Type: Article

References (21)

1. World Malaria Report 2012; World Health Organization: (2012.
2. Hyde, J. E. Drug-resistant malaria Trends Parasitol. 2005) 21, 494-8
3. Dondorp, A. M.; Yeung, S.; White, L.; Nguon, C.; Day, N. P.; Socheat, D.; von Seidlein, L. Artemisinin resistance: current status and scenarios for containment Nat. Rev. Microbiol. 2010, 8, 272-80
4. Burrows, J. N.; Chibale, K.; Wells, T. N. C. The State of the Art in Anti-malarial Drug Discovery and Development Curr. Top. Med. Chem. 2011, 11, 1226-1254
5. Burrows, J. N.; Burlot, E.; Campo, B.; Cherbuin, S.; Jeanneret, S.; Leroy, D.; Spangenberg, T.; Waterson, D.; Wells, T. N.; Willis, P. Antimalarial drug discovery-the path towards eradication Parasitology 2013, 1-12
6. Biamonte, M. A.; Wanner, J.; Le Roch, K. G. Recent advances in malaria drug discovery Bioorg. Med. Chem. Lett. 2013, 23, 2829-43
7. Gamo, F. J.; Sanz, L. M.; Vidal, J.; de Cozar, C.; Alvarez, E.; Lavandera, J. L.; Vanderwall, D. E.; Green, D. V.; Kumar, V.; Hasan, S.; Brown, J. R.; Peishoff, C. E.; Cardon, L. R.; Garcia-Bustos, J. F. Thousands of chemical starting points for antimalarial lead identification Nature 2010, 465, 305-10
8. Calderón, F.; Barros, D.; Bueno, J. M.; Coterón, J. M.; Fernández, E.; Gamo, F. J.; Lavandera, J. L.; León, M. L.; Macdonald, S. J. F.; Mallo, A.; Manzano, P.; Porras, E.; Fiandor, J. M.; Castro, J. An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS ACS Med. Chem. Lett. 2011, 2, 741-746
9. Coombs, G. H.; Goldberg, D. E.; Klemba, M.; Berry, C.; Kay, J.; Mottram, J. C. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets Trends Parasitol. 2001, 17, 532-7
10. Meyers, M. J.; Goldberg, D. E. Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts Curr. Top. Med. Chem. 2012, 12, 445-55
11. Boddey, J. A.; Hodder, A. N.; Gunther, S.; Gilson, P. R.; Patsiouras, H.; Kapp, E. A.; Pearce, J. A.; de Koning-Ward, T. F.; Simpson, R. J.; Crabb, B. S.; Cowman, A. F. An aspartyl protease directs malaria effector proteins to the host cell Nature 2010, 463, 627-31
12. Russo, I.; Babbitt, S.; Muralidharan, V.; Butler, T.; Oksman, A.; Goldberg, D. E. Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte Nature 2010, 463, 632-636
13. Li, X.; Chen, H.; Bahamontes-Rosa, N.; Kun, J. F.; Traore, B.; Crompton, P. D.; Chishti, A. H. Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria Biochem. Biophys. Res. Commun. 2009, 380, 454-9
14. Harbut, M. B.; Patel, B. A.; Yeung, B. K.; McNamara, C. W.; Bright, A. T.; Ballard, J.; Supek, F.; Golde, T. E.; Winzeler, E. A.; Diagana, T. T.; Greenbaum, D. C. Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 21486-91
15. Ciana, C. L.; Siegrist, R.; Aissaoui, H.; Marx, L.; Racine, S.; Meyer, S.; Binkert, C.; de Kanter, R.; Fischli, C.; Wittlin, S.; Boss, C. Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold Bioorg. Med. Chem. Lett. 2013, 23, 658-62
16. Malamas, M. S.; Erdei, J.; Gunawan, I.; Turner, J.; Hu, Y.; Wagner, E.; Fan, K.; Chopra, R.; Olland, A.; Bard, J.; Jacobsen, S.; Magolda, R. L.; Pangalos, M.; Robichaud, A. J. Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors J. Med. Chem. 2010, 53, 1146-58
17. Cumming, J. N.; Smith, E. M.; Wang, L.; Misiaszek, J.; Durkin, J.; Pan, J.; Iserloh, U.; Wu, Y.; Zhu, Z.; Strickland, C.; Voigt, J.; Chen, X.; Kennedy, M. E.; Kuvelkar, R.; Hyde, L. A.; Cox, K.; Favreau, L.; Czarniecki, M. F.; Greenlee, W. J.; McKittrick, B. A.; Parker, E. M.; Stamford, A. W. Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor Bioorg. Med. Chem. Lett. 2012, 22, 2444-9
18. Li, X.; He, Z.; Chen, L.; Li, Y.; Li, Q.; Zhao, S.; Tao, Z.; Hu, W.; Qin, L.; Chen, X. Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo Parasitol. Res. 2011, 109, 1519-24
19. Liu, J.; Gluzman, I. Y.; Drew, M. E.; Goldberg, D. E. The role of Plasmodium falciparum food vacuole plasmepsins J. Biol. Chem. 2005, 280, 1432-7
20. Omara-Opyene, A. L.; Moura, P. A.; Sulsona, C. R.; Bonilla, J. A.; Yowell, C. A.; Fujioka, H.; Fidock, D. A.; Dame, J. B. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy J. Biol. Chem. 2004, 279, 54088-96
21. Moura, P. A.; Dame, J. B.; Fidock, D. A. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors Antimicrob. Agents Chemother. 2009, 53, 4968-78